← Back to Clinical Trials
Recruiting NCT06639139

NCT06639139 The Effectiveness of Cognitive-Functional Remote Group Intervention (Cog-Fun RG) for Adults with Attention Deficit Hyperactivity Disorder (ADHD)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06639139
Status Recruiting
Phase
Sponsor Hebrew University of Jerusalem
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-11
Primary Completion 2025-10

Trial Parameters

Condition ADHD
Sponsor Hebrew University of Jerusalem
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2024-11
Completion 2025-10
Interventions
CogFun RG occupational therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to examine the effectiveness of Cognitive-Functional Remote Group intervention (Cog-Fun RG). The main questions of this study are 1. will participants demonstrate improvements in their executive functioning and quality of life after receiving the intervention, compared to waitlist controls. In addition, the investigators will examine if the waitlist group will demonstrate similar gains in these outcomes after receiving the same intervention. the investigators will compare between the intervention group to the waiting list group to examine the effect of the intervention. The participants will be allocated into two groups: an intervention group and a waiting list group. The intervention group will receive the the Cog-Fun RG intervention, which includes 21 weekly group sessions, each lasting 90 minutes. the participants will be required to complete questionnaires at several time points: pre-post the intervention, as well as three months, six months, and one year after the intervention. The waiting list controls will be required to complete questionnaires at several time points: pre-post waiting period, and then after the intervention, as well as three months, six months, and one year after the intervention.

Eligibility Criteria

Inclusion Criteria: \* Self Reported ADHD diagnoses Exclusion Criteria: \* Self Reported other major health condition that impedes daily functioning

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology